世界の臨床化学分析装置市場(~2026年):製品別(完全自動分析装置、PoC分析装置、試薬)、試験タイプ別(基礎代謝、肝臓、腎臓、脂質、甲状腺機能)、エンドユーザー別(病院、診療所、実験室、研究)

◆英語タイトル:Clinical Chemistry Analyzers Market by Product (Fully-Automated Analyzers, PoC Analyzers, Reagents), Test Type (Basic Metabolic, Liver, Renal, Lipid, Thyroid Function), End User (Hospitals, Clinics, Laboratories, Research) – Global Forecast to 2026
◆商品コード:MD2843
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2021年2月20日
◆ページ数:151
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

マーケッツアンドマーケッツ社は世界の臨床化学分析装置市場規模が2021年123億ドルから2026年152億ドルまで、年平均4.3%成長すると予想しています。本調査レポートでは、臨床化学分析装置の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(試薬、分析装置、その他)分析、試験タイプ別(基礎代謝パネル、肝臓パネル、腎臓プロファイル、脂質プロファイル、甲状腺機能パネル、その他)分析、エンドユーザー別(病院・診療所、診断研究室、研究所・機関、その他)分析、地域別分析、競争状況、企業情報などをまとめております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の臨床化学分析装置市場規模:製品別(試薬、分析装置、その他)
・世界の臨床化学分析装置市場規模:試験タイプ別(基礎代謝パネル、肝臓パネル、腎臓プロファイル、脂質プロファイル、甲状腺機能パネル、その他)
・世界の臨床化学分析装置市場規模:エンドユーザー別(病院・診療所、診断研究室、研究所・機関、その他)
・世界の臨床化学分析装置市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The global clinical chemistry analyzers market size is projected to reach USD 15.2 billion by 2026 from USD 12.3 billion in 2021, at a CAGR of 4.3% during the forecast period.”
Market growth is driven by factors such as the rising geriatric population and the increasing prevalence of chronic & lifestyle diseases, growing adoption of Point-of-Care testing devices and rising demand for laboratory automation. On the other hand, high capital investment, shortage of clinical laboratory technicians, and the availability of refurbished products is expected to limit market growth to a certain extent in the coming years.

“The reagents accounted for the highest growth rate in the clinical chemistry analyzers market, by product, during the forecast period”
The clinical chemistry analyzers market is segmented into analyzers, reagents and other products. The reagents segment accounted for the highest growth rate in the clinical chemistry analyzers market in 2020. The requirement reagents in large numbers compared to analyzers is the main factor contributing to this segment’s high growth rate. This segment’s market growth can also be attributed to repeat purchases of reagents compared to analyzers.

“Lipid profile tests segment accounted for the highest CAGR”
Based on the test type, the clinical chemistry analyzers market is segmented basic metabolic panels, electrolyte panels, liver panels, lipid profiles, renal profiles, thyroid function panels, and specialty chemical tests. In 2020, the lipid profile tests segment accounted for the highest growth rate. Rapid growth in obesity rates and the increasing incidence of obesity-related diseases are the major factors driving this segment’s growth.

“Hospitals and clinics segment accounted for the highest CAGR”
Based on end-users, the clinical chemistry analyzers market is segmented into hospitals and clinics, diagnostic laboratories, research laboratories & institutes, and other end users. In 2020, the hospitals and clinics segment accounted for the highest growth rate. This can be attributed to increasing number of hospitals worldwide owing to the increasing incidences of diseases & disorders, increasing adoption of analyzers and rising technological advancements.

“Asia Pacific: The fastest-growing region clinical chemistry analyzers market”
The global clinical chemistry analyzers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Growth in this region is expected to be centered on China and Japan. Factors such as the rising geriatric population, high burden of chronic diseases, growing per capita income, increasing investments in the healthcare industry by key market players, rising demand for cutting-edge technologies, expansion of private-sector hospitals to rural areas in various APAC countries, an increasing number of hospitals and clinicsare driving the growth of the clinical chemistry analyzers market in this region.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 20%, Tier 2 – 45%, and Tier 3 – 35%
• By Designation: C-level – 30%, D-level – 20%, and Others – 50%
• By Region: North America – 36%, Europe – 25%, Asia Pacific – 27%, Latin America – 9% , and the Middle East & Africa – 3%

Lits of Companies Profiled in the Report:
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Danaher Corporation (US)
• Abbott Laboratories (US)
• Thermo Fisher Scientific Inc. (US)
• Siemens AG (Germany)
• HORIBA Ltd. (Japan)
• Sysmex Corporation (Japan)
• HITACHI (Japan)
• EKF Diagnostics (UK)
• Ortho Clinical Diagnostics (US)
• ELITech Group (France)
• Mindray Medical International Ltd. (China)
• BIOBASE Group (China)
• SFRI Medical Diagnostics (France)
• Trivitron Healthcare Pvt. Ltd. (India)
• Randox Laboratories Ltd. (UK)
• Medica Corporation (US)
• Meril Life Sciences Pvt. Ltd. (India)
• Erba Mannheim (UK)
• Genrui Biotech Inc. (China)
• DIRUI Industrial Co. Ltd. (China)
• Teco Diagnostics (US)
• Balio Diagnostics (France)
• Snibe Co. Ltd. (China)
• AMS Alliance (Italy)

Research Coverage:
This report provides a detailed picture of the global clinical chemistry analyzers market. It aims at estimating the size and future growth potential of the market across different segments, such as product, test type, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall clinical chemistry analyzers market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, trends, and opportunities.

【レポートの目次】

1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
FIGURE 1 INCLUSIONS & EXCLUSIONS 24
1.2.1 MARKETS COVERED 25
FIGURE 2 CLINICAL CHEMISTRY ANALYZERS MARKET 25
1.2.2 YEARS CONSIDERED FOR THE STUDY 25
1.3 CURRENCY 26
1.4 LIMITATIONS 26
1.5 STAKEHOLDERS 26
1.6 SUMMARY OF CHANGES 26
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
2.2 RESEARCH APPROACH 28
FIGURE 3 CLINICAL CHEMISTRY ANALYZERS MARKET: RESEARCH DESIGN METHODOLOGY 28
2.2.1 SECONDARY DATA 29
2.2.1.1 Key data from secondary sources 29
2.2.2 PRIMARY DATA 30
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 30
2.2.2.1 Key data from primary sources 31
2.3 MARKET SIZE ESTIMATION 32
2.3.1 BOTTOM-UP APPROACH 32
FIGURE 5 CLINICAL CHEMISTRY ANALYZERS MARKET: BOTTOM-UP APPROACH 32
2.3.2 TOP-DOWN APPROACH 33
FIGURE 6 CLINICAL CHEMISTRY ANALYZER MARKET: TOP-DOWN APPROACH 33
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 34
FIGURE 7 DATA TRIANGULATION METHODOLOGY 34
2.5 ASSUMPTIONS FOR THE STUDY 35
3 EXECUTIVE SUMMARY 36
FIGURE 8 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 36
FIGURE 9 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 37
FIGURE 10 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2021 VS. 2026 (USD MILLION) 37
FIGURE 11 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 38
FIGURE 12 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION,
2021 VS. 2026 (USD MILLION) 39
4 PREMIUM INSIGHTS 40
4.1 CLINICAL CHEMISTRY ANALYZERS MARKET OVERVIEW 40
FIGURE 13 THE RISING ADOPTION OF POC PRODUCTS IS EXPECTED TO SUPPORT MARKET GROWTH DURING THE FORECAST PERIOD 40
4.2 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 41
FIGURE 14 THE REAGENTS SEGMENT IS EXPECTED TO COMMAND THE LARGEST SHARE OF THE MARKET, BY PRODUCT, IN 2021 41
4.3 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 41
FIGURE 15 THE SEMI-AUTOMATIC ANALYZER SEGMENT IS EXPECTED TO HOLD THE LARGEST SHARE OF THE MARKET, BY TYPE, DURING THE FORECAST PERIOD 41
4.4 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2021 VS. 2026 42
FIGURE 16 THE ASIA PACIFIC MARKET IS ESTIMATED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 43
5.2 MARKET DYNAMICS 43
FIGURE 17 CLINICAL CHEMISTRY ANALYZER MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS 43
5.2.1 DRIVERS 44
5.2.1.1 Rising geriatric population and the increasing prevalence of chronic & lifestyle diseases 44
TABLE 1 ESTIMATED INCREASE IN THE GERIATRIC POPULATION,
BY REGION (2019-2050) 44
5.2.1.2 Growing adoption of Point-of-Care testing devices 45
5.2.1.3 Increasing demand for laboratory automation 46
5.2.2 RESTRAINTS 46
5.2.2.1 The requirement of high capital investments and a shortage of skilled laboratory technicians 46
5.2.2.2 Availability of refurbished analyzers 47
5.2.3 OPPORTUNITIES 47
5.2.3.1 Increasing government initiatives and funding for preventive care 47
5.2.4 TRENDS 47
5.2.4.1 Multichannel operations of integrated analyzers 47
5.2.5 COVID 19 IMPACT ANALYSIS 48
5.3 PRICING ANALYSIS 49
TABLE 2 AVERAGE SELLING PRICES OF PRODUCTS (USD) 49
5.4 VALUE CHAIN ANALYSIS 49
FIGURE 18 VALUE CHAIN ANALYSIS OF THE CLINICAL CHEMISTRY ANALYZERS MARKET 49
5.5 SUPPLY CHAIN ANALYSIS 49
FIGURE 19 SUPPLY CHAIN ANALYSIS 50
5.6 ECOSYSTEM ANALYSIS 51
5.7 PORTER’S FIVE FORCES ANALYSIS 52
FIGURE 20 PORTER’S FIVE FORCES ANALYSIS 52
5.7.1 THREAT FROM NEW ENTRANTS 52
5.7.2 THREAT FROM SUBSTITUTES 52
5.7.3 BARGAINING POWER OF BUYERS 53
5.7.4 BARGAINING POWER OF SUPPLIERS 53
5.7.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 53
5.8 PESTLE ANALYSIS 54
6 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT 55
6.1 INTRODUCTION 56
TABLE 3 CLINICAL CHEMISTRY REAGENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 56
6.2 REAGENTS 56
6.2.1 THE RECURRENT PURCHASE REQUIREMENT OF REAGENTS DRIVES MARKET GROWTH 56
TABLE 4 CLINICAL CHEMISTRY REAGENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 57
6.3 ANALYZERS 57
TABLE 5 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 57
TABLE 6 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION,
2019–2026 (USD MILLION) 58
6.3.1 SEMI-AUTOMATIC ANALYZERS 58
6.3.1.1 The cost-effectiveness of semi-automatic analyzers drives segment growth 58
TABLE 7 SEMI-AUTOMATIC ANALYZERS MARKET, BY REGION,
2019–2026 (USD MILLION) 58
6.3.2 FULLY AUTOMATIC ANALYZERS 59
6.3.2.1 Fully automatic analyzers offer rapid sample processing, thus enhancing workflows 59
TABLE 8 FULLY AUTOMATIC ANALYZERS MARKET, BY REGION,
2019–2026 (USD MILLION) 59
6.3.3 POINT-OF-CARE ANALYZERS 59
6.3.3.1 The increasing adoption of PoC technologies drives segment growth 59
TABLE 9 POINT-OF-CARE ANALYZERS MARKET, BY REGION,
2019–2026 (USD MILLION) 60
6.4 OTHER PRODUCTS 60
TABLE 10 CLINICAL CHEMISTRY ANALYZERS FOR OTHER PRODUCTS MARKET,
BY REGION, 2019–2026 (USD MILLION) 60

7 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE 61
7.1 INTRODUCTION 62
TABLE 11 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 62
7.2 BASIC METABOLIC PANEL 62
7.2.1 THE RISING INCIDENCE OF DIABETES AND OTHER CHRONIC DISEASES IS A PRIMARY GROWTH DRIVER FOR THIS SEGMENT 62
TABLE 12 BASIC METABOLIC PANEL TESTS MARKET, BY REGION,
2019–2026 (USD MILLION) 63
7.3 LIVER PANEL 63
7.3.1 THE INCREASING INCIDENCE OF LIVER-RELATED DISEASES IS A KEY FACTOR DRIVING MARKET GROWTH 63
TABLE 13 LIVER PANEL TESTS MARKET, BY REGION, 2019–2026 (USD MILLION) 64
7.4 RENAL PROFILE 64
7.4.1 THE RISING INCIDENCE OF ESRD PATIENTS DRIVES THE GROWTH OF THE RENAL PROFILE TESTING MARKET 64
TABLE 14 RENAL PROFILE TESTS MARKET, BY REGION, 2019–2026 (USD MILLION) 64
7.5 LIPID PROFILE 65
7.5.1 LIPID PROFILE TESTS ARE PRESCRIBED TO MONITOR UNHEALTHY LIPID LEVELS AND AVOID CVD RISKS 65
TABLE 15 LIPID PROFILE TESTS MARKET, BY REGION, 2019–2026 (USD MILLION) 65
7.6 THYROID FUNCTION PANEL 65
7.6.1 THE INCREASING INCIDENCE OF THYROID-RELATED DISORDERS DRIVES THE GROWTH OF THIS SEGMENT 65
TABLE 16 THYROID FUNCTION PANEL TESTS MARKET, BY REGION,
2019–2026 (USD MILLION) 66
7.7 ELECTROLYTE PANEL 66
7.7.1 THE ELECTROLYTE TEST PANEL IS PRESCRIBED TO PATIENTS THAT SUFFER FROM HYPERTENSION OR LIVER & KIDNEY DISEASES 66
TABLE 17 ELECTROLYTE PANEL TESTS MARKET, BY REGION,
2019–2026 (USD MILLION) 66
7.8 SPECIALTY CHEMICAL TESTS 67
7.8.1 THIS SEGMENT IS EXPECTED TO GROW AT THE LOWEST CAGR DURING THE FORECAST PERIOD AS THESE TESTS ARE NOT PRESCRIBED REGULARLY 67
TABLE 18 SPECIALTY CHEMICAL TESTS MARKET, BY REGION,
2019–2026 (USD MILLION) 67
8 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER 68
8.1 INTRODUCTION 69
TABLE 19 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 69
8.2 HOSPITALS AND CLINICS 69
8.2.1 HOSPITALS ARE THE MAJOR END USERS OF CLINICAL CHEMISTRY ANALYZERS 69
TABLE 20 CLINICAL CHEMISTRY ANALYZERS MARKET FOR HOSPITALS AND CLINICS,
BY REGION, 2019–2026 (USD MILLION) 70
8.3 DIAGNOSTIC LABORATORIES 70
8.3.1 INCREASING OUTSOURCING ACTIVITIES TO DIAGNOSTIC LABORATORIES FOR REDUCED COSTS DRIVE THE GROWTH OF THIS SEGMENT 70
TABLE 21 CLINICAL CHEMISTRY ANALYZERS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2019–2026 (USD MILLION) 71
8.4 RESEARCH LABORATORIES & INSTITUTES 71
8.4.1 GROWTH IN FUNDING FOR LIFE SCIENCE RESEARCH IS A PRIMARY DRIVER FOR THIS END-USER SEGMENT 71
TABLE 22 CLINICAL CHEMISTRY ANALYZERS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2019–2026 (USD MILLION) 71
8.5 OTHER END USERS 72
TABLE 23 CLINICAL CHEMISTRY ANALYZERS MARKET FOR OTHER END USERS,
BY REGION, 2019–2026 (USD MILLION) 72
9 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION 73
9.1 INTRODUCTION 74
TABLE 24 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION,
2019–2026 (USD MILLION) 74
9.2 NORTH AMERICA 74
FIGURE 21 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET SNAPSHOT 75
TABLE 25 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 75
TABLE 26 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 76
TABLE 27 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 76
TABLE 28 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION) 76
TABLE 29 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION) 77
9.2.1 US 77
9.2.1.1 Increasing cases of diabetes & obesity-related diseases is a key factor expected to drive market growth 77
TABLE 30 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 78
TABLE 31 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 78
TABLE 32 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 78
TABLE 33 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 79
9.2.2 CANADA 79
9.2.2.1 The increasing prevalence of chronic & lifestyle diseases drives the market growth in Canada 79
TABLE 34 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 80
TABLE 35 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 80
TABLE 36 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 80
TABLE 37 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 81
9.3 EUROPE 81
TABLE 38 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 81
TABLE 39 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 82
TABLE 40 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 82
TABLE 41 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 82
TABLE 42 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 83
9.3.1 UK 83
9.3.1.1 The increasing number of accredited clinical laboratories in the UK propels market growth for chemical analyzers 83
TABLE 43 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 84
TABLE 44 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 84
TABLE 45 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 84
TABLE 46 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 85
9.3.2 GERMANY 85
9.3.2.1 Increasing healthcare expenditure to drive market growth in Germany 85
TABLE 47 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 85
TABLE 48 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 86
TABLE 49 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 86
TABLE 50 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 86
9.3.3 FRANCE 87
9.3.3.1 Rising R&D expenditure in France to drive market growth 87
TABLE 51 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 87
TABLE 52 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 87
TABLE 53 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 88
TABLE 54 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 88

9.3.4 ITALY 88
9.3.4.1 Age-related chronic conditions owing to a large geriatric population to drive market growth in Italy 88
TABLE 55 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 89
TABLE 56 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 89
TABLE 57 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 89
TABLE 58 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 90
9.3.5 SPAIN 90
9.3.5.1 Increasing prevalence of age-associated disorders to drive market growth in Spain 90
TABLE 59 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 90
TABLE 60 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 91
TABLE 61 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 91
TABLE 62 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 91
9.3.6 RUSSIA 92
9.3.6.1 Increasing access to quality healthcare will support market growth in Russia 92
TABLE 63 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 92
TABLE 64 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 92
TABLE 65 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 93
TABLE 66 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 93
9.3.7 REST OF EUROPE (ROE) 93
TABLE 67 ROE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 94
TABLE 68 ROE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 94
TABLE 69 ROE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 94
TABLE 70 ROE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 95
9.4 ASIA PACIFIC 95
FIGURE 22 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET SNAPSHOT 96
TABLE 71 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 96
TABLE 72 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 97
TABLE 73 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 97
TABLE 74 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 97
TABLE 75 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 98
9.4.1 CHINA 98
9.4.1.1 China accounted for the largest share of the APAC market in 2020 98
TABLE 76 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 99
TABLE 77 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 99
TABLE 78 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 99
TABLE 79 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 100
9.4.2 JAPAN 100
9.4.2.1 A favorable regulatory framework to drive market growth in Japan 100
TABLE 80 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 101
TABLE 81 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 101
TABLE 82 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 101
TABLE 83 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 102
9.4.3 INDIA 102
9.4.3.1 Increasing private & public investments in the country’s healthcare system will drive market growth 102
TABLE 84 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 103
TABLE 85 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 103
TABLE 86 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 103
TABLE 87 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 104
9.4.4 REST OF ASIA PACIFIC (ROAPAC) 104
TABLE 88 ROAPAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 104
TABLE 89 ROAPAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 105
TABLE 90 ROAPAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 105
TABLE 91 ROAPAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 105

9.5 LATIN AMERICA 106
TABLE 92 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 106
TABLE 93 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 107
TABLE 94 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION) 107
TABLE 95 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION) 107
9.6 MIDDLE EAST AND AFRICA 108
TABLE 96 MEA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 108
TABLE 97 MEA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 108
TABLE 98 MEA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,
2019–2026 (USD MILLION) 109
TABLE 99 MEA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2019–2026 (USD MILLION) 109
10 COMPETITIVE LANDSCAPE 110
10.1 OVERVIEW 110
FIGURE 23 KEY DEVELOPMENTS IN THE CLINICAL CHEMISTRY ANALYZERS MARKET 110
10.2 MARKET SHARE ANALYSIS 111
FIGURE 24 CLINICAL CHEMISTRY ANALYZERS MARKET SHARE, BY KEY PLAYER (2019) 111
10.3 COMPANY EVALUATION QUADRANT 111
10.3.1 LIST OF EVALUATED VENDORS 111
10.3.2 STARS 111
10.3.3 EMERGING LEADERS 112
10.3.4 PERVASIVE PLAYERS 112
10.3.5 PARTICIPANTS 112
FIGURE 25 CLINICAL CHEMISTRY ANALYZERS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019 113
10.4 COMPETITIVE EVALUATION MATRIX FOR START-UPS (2019) 114
10.4.1 PROGRESSIVE COMPANIES 114
10.4.2 STARTING BLOCKS 114
10.4.3 RESPONSIVE COMPANIES 114
10.4.4 DYNAMIC COMPANIES 114
FIGURE 26 CLINICAL CHEMISTRY ANALYZERS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS, 2019 115
10.5 COMPETITIVE SCENARIO 116
10.5.1 PRODUCT LAUNCHES 116
TABLE 100 KEY PRODUCT LAUNCHES 116
10.5.2 ACQUISITIONS 116
TABLE 101 KEY ACQUISITIONS 116
10.5.3 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 117
TABLE 102 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 117
10.5.4 EXPANSIONS 117
TABLE 103 KEY EXPANSIONS 117
11 COMPANY PROFILES 118
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1 ROCHE DIAGNOSTICS LTD. 118
FIGURE 27 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019) 118
11.2 DANAHER CORPORATION 120
FIGURE 28 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 120
11.3 ABBOTT LABORATORIES 122
FIGURE 29 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019) 122
11.4 THERMO FISHER SCIENTIFIC INC. 125
FIGURE 30 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019) 125
11.5 SIEMENS HEALTHINEERS AG 127
FIGURE 31 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 127
11.6 HORIBA, LTD. 129
FIGURE 32 HORIBA LTD.: COMPANY SNAPSHOT (2019) 129
11.7 SYSMEX CORPORATION 131
FIGURE 33 SYSMEX CORPORATION: COMPANY SNAPSHOT (2019) 131
11.8 EKF DIAGNOSTICS 133
FIGURE 34 EKF DIAGNOSTICS: COMPANY SNAPSHOT 133
11.9 HITACHI 135
FIGURE 35 HITACHI LTD.: COMPANY SNAPSHOT (2019) 135
11.10 ORTHO CLINICAL DIAGNOSTICS 136
11.10.1 BUSINESS OVERVIEW 136
11.10.2 PRODUCTS OFFERED 136
11.10.3 RECENT DEVELOPMENTS 136
11.11 ELITECHGROUP 137
11.12 MINDRAY MEDICAL INTERNATIONAL LTD. 138
11.13 BIOBASE GROUP 139
11.14 SFRI MEDICAL DIAGNOSTICS 140
11.15 TRIVITRON HEALTHCARE PVT. LTD. 141
11.16 RANDOX LABORATORIES LTD. 143
11.17 MEDICA CORPORATION 143
11.18 MERIL LIFE SCIENCES PVT. LTD. 144
11.19 ERBA MANNHEIM 145
11.20 GENRUI BIOTECH INC. 145
11.21 DIRUI INDUSTRIAL CO., LTD. 146
11.22 TECO DIAGNOSTICS 147
11.23 BALIO DIAGNOSTICS 147
11.24 SNIBE CO. LTD. 148
11.25 AMS ALLIANCE 148
*Details on Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
12 APPENDIX 149
12.1 INSIGHTS FROM INDUSTRY EXPERTS 149
12.2 DISCUSSION GUIDE 150
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 152
12.4 AVAILABLE CUSTOMIZATIONS 154
12.5 RELATED REPORTS 154
12.6 AUTHOR DETAILS 155



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の臨床化学分析装置市場(~2026年):製品別(完全自動分析装置、PoC分析装置、試薬)、試験タイプ別(基礎代謝、肝臓、腎臓、脂質、甲状腺機能)、エンドユーザー別(病院、診療所、実験室、研究)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆